Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Here Comes $10 for QuantumScape Stock

By Will Ashworth, InvestorPlace Contributor
The solid-state lithium-metal electric battery startup is down 79% from a 52-week high. Little stands in the way of QS stock falling further.

Chances of a Blockbuster Sequel for AMC Stock Are Looking Slim

By Faizan Farooque, InvestorPlace Contributor
Recent ticket sales are heartening but AMC stock needs to 'pull a rabbit out of a hat' to repeat its 2021 performance and regain momentum.

Facing Tough Short and Long Term Issues, Matterport Stock May Be in Trouble

By Larry Ramer, InvestorPlace Contributor
The valuation of MTTR stock is elevated, while Matterport is facing difficult issues in both the short term and the long term.

The Party Is Over for AMC Entertainment Stock

By Dana Blankenhorn, InvestorPlace Contributor
Investors should wait for the next big thing, for Virtual Reality or Augmented Reality entertainment, rather than waste money on 20th century plays like AMC.

The Story Just Keeps Getting Worse for GameStop

By Patrick Sanders, InvestorPlace Contributor
GameStop just can't stop the bleeding. GME stock has fallen below $100 for the first time since it rocketed to ridiculous levels a year ago.

It’s Time to Go Back to the Basics With AMC Entertainment

By Josh Enomoto, InvestorPlace Contributor
While AMC stock has certainly delivered a fun ride for speculators, the ship is no longer being steered by the captain.

ContextLogic Already Imposed the Pain That Hurts… Now for the Pain That Alters

By Josh Enomoto, InvestorPlace Contributor
Although we live in a period where anything can happen, you don’t want to let that be the core reason to hold WISH stock.

Sea Limited Is Trading at Low Prices, But That Doesn’t Make It a Good Value

By David Moadel, InvestorPlace Contributor
After a share-price smackdown, SE stock might entice contrarian investors. Yet, a closer look at Sea Limited's financial reveals problems.

Novavax Appears to be Running Out of Options

By Josh Enomoto, InvestorPlace Contributor
With time appearing to run out and fewer people willing to get vaccinated, NVAX stock seems to be an abandon-ship investment at this point.

Rumble Is Not the Next YouTube And SPAC CF Acquisition Won’t Make It One

By Stavros Georgiadis, CFA, InvestorPlace Contributor
CFVI stock is another SPAC that has extreme risk, overstretched valuation, and former President Trump as a brand name to support, but this reason is too naïve to invest in it now.

5 Important Investing Lessons From Allakos’ Price Collapse

By Stavros Georgiadis, CFA, InvestorPlace Contributor
ALLK stock is a gamble now even after falling about 85% off its 52-week high. Allakos' slide offers investors with a learning opportunity.

Expect ‘Cheap’ SmileDirectClub Stock to Only Get Cheaper From Here

By Louis Navellier and the InvestorPlace Research Staff
With little indication that its new product lines will take off or that its aligning products will regain popularity, take a hard pass on SDC stock.

There Is No Positive Catalyst That Can Revive DraftKings Now

By Louis Navellier and the InvestorPlace Research Staff
As DraftKings' outlays far exceed the company's revenues, it's only getting harder to hold fast-declining DKNG stock with confidence.

Find Another Machine Learning Investment Besides C3.ai

By Louis Navellier and the InvestorPlace Research Staff
The trend is definitely not the friend of AI stock holders, and turnaround hopes are fading as the company's risks outweigh its advantages.

Can NFTs Save GameStop? Don’t Count on It.

By Joel Baglole, InvestorPlace Contributor
GameStop's plan to develop an NFT marketplace is unlikely to help the video game retailer or GME stock long term.

Novavax Is Fighting a Losing Battle on Two Fronts

By Will Ashworth, InvestorPlace Contributor
Novavax could be losing ground in the vaccine war because it’s fighting a battle on two fronts. This isn’t helping NVAX stock move higher.

Is Social Media Giving Off Hints of ContextLogic’s Fissures?

By Josh Enomoto, InvestorPlace Contributor
Although WISH stock once carried speculator hopes, the vituperative nature of its social media posts may be a sign -- a bad one.

Price-Target Chop Job Is the Least of Virgin Galactic’s Problems

By David Moadel, InvestorPlace Contributor
When the only recently issued news from Virgin Galactic has little to do with spacecraft launches, it's time to lean bearish on SPCE stock.

Despite Palantir’s Impressive Deals, Its Losses and Valuation Make It Unappetizing

By Larry Ramer, InvestorPlace Contributor
Amid continued questions about the profitability and competitive advantages of Palantir, PLTR stock remains a sell.
Load More Articles